Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment

Pancreas

Volumn 40, Issue 5, 2011, Pages 644-652

  Singh, Puneet ^a,b   Srinivasan, Radhika ^a   Wig, Jai Dev ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

diagnosis; Molecular markers; pancreatic ductal adenocarcinoma; prognosis; screening; therapeutics

Indexed keywords

AROTINOID; AXITINIB; BEVACIZUMAB; BRCA2 PROTEIN; CAPECITABINE; CETUXIMAB; CYCLIN D1; EPIDERMAL GROWTH FACTOR; ERLOTINIB; FARNESOL; FIBROBLAST GROWTH FACTOR; GEFITINIB; GEMCITABINE; GERANIOL; MATRIX METALLOPROTEINASE; MICRORNA; MITOMYCIN C; MOFAROTENE; MOLECULAR MARKER; PERILLYL ALCOHOL; PROTEIN KINASE SYK; PROTEIN P21; PROTEIN P27; PROTEIN P53; SMAD4 PROTEIN; SOMATOSTATIN; TRANSFORMING GROWTH FACTOR; UNINDEXED DRUG; VASCULOTROPIN; VITAMIN D DERIVATIVE;

ALLELE; ANGIOGENESIS; APOPTOSIS; ASPIRATION CYTOLOGY; AUTOPHOSPHORYLATION; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CANCER THERAPY; CARCINOGENICITY; CELL CYCLE ARREST; CELL CYCLE PHASE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRESS; CELL SURVIVAL; CELL VIABILITY; CHEMORADIOTHERAPY; CHEMOTHERAPY; CHROMOSOME 9Q; CHRONIC PANCREATITIS; CODON; DNA METHYLATION; DNA REPAIR; DOWN REGULATION; DRUG BINDING; DYSPLASIA; ENVIRONMENTAL FACTOR; FIBROBLAST; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; GENE THERAPY; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; HUMAN; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; LYMPHANGIOGENESIS; MELANOMA; MITOSIS INHIBITION; ONCOGENE; ONCOGENE K RAS; PANCREAS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PAPILLARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RETINOBLASTOMA; REVIEW; TREATMENT RESPONSE; TUMOR GROWTH;

CARCINOMA, PANCREATIC DUCTAL; CELL CYCLE; GENES, BRCA2; GENES, P16; GENES, P53; GENES, RAS; GROWTH SUBSTANCES; HUMANS; MASS SCREENING; MATRIX METALLOPROTEINASES; MICRORNAS; MUTATION; PANCREATIC NEOPLASMS; PROGNOSIS; RNA, NEOPLASM; SMAD4 PROTEIN; TRANSLATIONAL RESEARCH; TUMOR MARKERS, BIOLOGICAL;

EID: 79959837073     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31821ff741     Document Type: Review

References (0)